Radiomics Nomogram for the Prediction of 2019 Novel Coronavirus Pneumonia Caused by SARS-CoV-2
Overview
Authors
Affiliations
Objectives: To develop and validate a radiomics model for predicting 2019 novel coronavirus (COVID-19) pneumonia.
Methods: For this retrospective study, a radiomics model was developed on the basis of a training set consisting of 136 patients with COVID-19 pneumonia and 103 patients with other types of viral pneumonia. Radiomics features were extracted from the lung parenchyma window. A radiomics signature was built on the basis of reproducible features, using the least absolute shrinkage and selection operator method (LASSO). Multivariable logistic regression model was adopted to establish a radiomics nomogram. Nomogram performance was determined by its discrimination, calibration, and clinical usefulness. The model was validated in 90 consecutive patients, of which 56 patients had COVID-19 pneumonia and 34 patients had other types of viral pneumonia.
Results: The radiomics signature, consisting of 3 selected features, was significantly associated with COVID-19 pneumonia (p < 0.05) in both training and validation sets. The multivariable logistic regression model included the radiomics signature and distribution; maximum lesion, hilar, and mediastinal lymph node enlargement; and pleural effusion. The individualized prediction nomogram showed good discrimination in the training sample (area under the receiver operating characteristic curve [AUC], 0.959; 95% confidence interval [CI], 0.933-0.985) and in the validation sample (AUC, 0.955; 95% CI, 0.899-0.995) and good calibration. The mixed model achieved better predictive efficacy than the clinical model. Decision curve analysis demonstrated that the radiomics nomogram was clinically useful.
Conclusions: The radiomics model derived has good performance for predicting COVID-19 pneumonia and may help in clinical decision-making.
Key Points: • A radiomics model showed good performance for prediction 2019 novel coronavirus pneumonia and favorable discrimination for other types of pneumonia on CT images. • A central or peripheral distribution, a maximum lesion range > 10 cm, the involvement of all five lobes, hilar and mediastinal lymph node enlargement, and no pleural effusion is associated with an increased risk of 2019 novel coronavirus pneumonia. • A radiomics model was superior to a clinical model in predicting 2019 novel coronavirus pneumonia.
A nomogram to predict severe COVID-19 patients with increased pulmonary lesions in early days.
Chen L, Li M, Wu Z, Liu S, Huang Y Front Med (Lausanne). 2024; 11:1343661.
PMID: 38737763 PMC: 11082326. DOI: 10.3389/fmed.2024.1343661.
Fang X, Shi F, Liu F, Wei Y, Li J, Wu J Radiologie (Heidelb). 2024; 64(Suppl 1):66-75.
PMID: 38446170 DOI: 10.1007/s00117-024-01275-3.
Chu W, Castro M, Reza S, Cooper T, Bartlinski S, Bradley D Sci Rep. 2023; 13(1):19607.
PMID: 37950044 PMC: 10638262. DOI: 10.1038/s41598-023-46694-9.
Artificial Intelligence and Infectious Disease Imaging.
Chu W, Reza S, Anibal J, Landa A, Crozier I, Bagci U J Infect Dis. 2023; 228(Suppl 4):S322-S336.
PMID: 37788501 PMC: 10547369. DOI: 10.1093/infdis/jiad158.
Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19.
Aminu M, Yadav D, Hong L, Young E, Edelkamp Jr P, Saad M Cancers (Basel). 2023; 15(1).
PMID: 36612278 PMC: 9818576. DOI: 10.3390/cancers15010275.